LAVA Therapeutics
LVTX
LVTX
20 hedge funds and large institutions have $44.3M invested in LAVA Therapeutics in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$24K |
| 2 |
Axa
Paris,
France
|
+$15.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.5K |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$426K |
| 2 |
Millennium Management
New York
|
-$168K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$109K |
| 4 |
AWG
Alpha Wave Global
New York
|
-$105K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$46.6K |
